Table 2.

Characteristics of the sibling umbilical cord blood

Collection to infusion time   28 days  
FA genotype   IVS 4 + 4 A>T heterozygous (carrier)  
DEB and mitomycin C testing   In normal range and similar to healthy control sample  
HLA-type  
UCB   HLA-A2, -A26 -B35, -B44, -DRB1*0402, DRB1*1001  
Patient   HLA-A2, -A26 -B35, -B44, -DRB1*0402, DRB1*1001  
Blood group  
UCB   O Rh-positive  
Patient   O Rh-positive  
CMV and EBV immunoglobulin M   Negative  
Nucleated cells  
At harvest   2.5 × 107/kg of recipient  
After thawing   1.6 × 107/kg of recipient  
CD34+ cells (after thawing)   1.8 × 105/kg of recipient  
CD3+ cells   0.4 × 107/kg of recipient  
Clonogenic assays (after thawing)
 
22.5 CFU/100 000 cells plated
 
Collection to infusion time   28 days  
FA genotype   IVS 4 + 4 A>T heterozygous (carrier)  
DEB and mitomycin C testing   In normal range and similar to healthy control sample  
HLA-type  
UCB   HLA-A2, -A26 -B35, -B44, -DRB1*0402, DRB1*1001  
Patient   HLA-A2, -A26 -B35, -B44, -DRB1*0402, DRB1*1001  
Blood group  
UCB   O Rh-positive  
Patient   O Rh-positive  
CMV and EBV immunoglobulin M   Negative  
Nucleated cells  
At harvest   2.5 × 107/kg of recipient  
After thawing   1.6 × 107/kg of recipient  
CD34+ cells (after thawing)   1.8 × 105/kg of recipient  
CD3+ cells   0.4 × 107/kg of recipient  
Clonogenic assays (after thawing)
 
22.5 CFU/100 000 cells plated
 

The patient weighed 20.6 kg at admission for HSCT.